FDA Inspection 829873 — Summit Medical, Inc.
The FDA completed an inspection of Summit Medical, Inc. on May 2, 2013 in Baton Rouge, LA. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- May 2, 2013
- Fiscal Year
- 2013
- Product Type
- Biologics
- Project Area
- Human Cellular, Tissue, and Gene Therapies
- Location
- Baton Rouge, LA (United States)